Mural Oncology plc’s recently made public that its insider Keson-Brookes Maiken unloaded Company’s shares for reported $6379.0 on Jul 22 ’25. In the deal valued at $2.48 per share,2,572 shares were sold. As a result of this transaction, Keson-Brookes Maiken now holds 68,834 shares worth roughly $0.12 million.
Then, Keson-Brookes Maiken sold 2,158 shares, generating $5,352 in total proceeds. Upon selling the shares at $2.48, the insider now owns 71,406 shares.
Before that, Maiken Keson-Brookes bought 2,572 shares. Mural Oncology plc shares valued at $6,404 were divested by the CLO at a price of $2.49 per share.
Raymond James downgraded its Mural Oncology plc [MURA] rating to an Outperform from a a Strong buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in late March from “an Overweight” to “an Equal-weight”. Rodman & Renshaw began covering MURA with “Buy” recommendation on June 28, 2024. Morgan Stanley started covering the stock on April 04, 2024. It rated MURA as “an Overweight”.
Price Performance Review of MURA
On Tuesday, Mural Oncology plc [NASDAQ:MURA] saw its stock fall -3.78% to $1.78. Over the last five days, the stock has lost -25.21%. Mural Oncology plc shares have fallen nearly -48.85% since the year began. Nevertheless, the stocks have fallen -44.72% over the past one year.
How much short interest is there in Mural Oncology plc?
A steep rise in short interest was recorded in Mural Oncology plc stocks on 2025-07-15, growing by 19910.0 shares to a total of 0.23 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 0.21 million shares. There was a rise of 8.56%, which implies that there is a positive sentiment for the stock.
